Professional Summary
Professional Overview
Chris Rubino is an accomplished Pharmacometrics professional with over 20 years of experience in the pharmaceutical and healthcare industries. As the Vice President of Pharmacometrics at the Institute for Clinical Pharmacodynamics, he leverages his deep expertise in translational medicine, pharmacokinetics, and data analysis to drive innovative drug development initiatives.
Experience Summary
Current Role
As the Vice President of Pharmacometrics at the Institute for Clinical Pharmacodynamics, Chris is responsible for leading a team of scientists in the development and application of pharmacometric models to support drug discovery and clinical development programs. He oversees the implementation of advanced modeling and simulation techniques to optimize study designs, guide dose selection, and inform decision-making throughout the drug development lifecycle. Under his leadership, the Institute has contributed to the successful advancement of several novel therapeutic candidates.
Career Progression
Prior to his current role, Chris held various positions in the pharmaceutical and healthcare sectors, including Senior Scientist in Translational Medicine at the Ordway Research Institute, Assistant Director of Pharmacy in Ambulatory Services at Roswell Park Cancer Institute, and Pediatric Pharmacologist at Cognigen Corporation. Throughout his career, he has demonstrated a strong track record of applying his expertise in pharmacokinetics, pharmacodynamics, and quantitative analysis to drive tangible improvements in patient outcomes and accelerate drug development processes.
Academic Background
Chris holds a Ph.D. in Pharmaceutical Sciences from the University at Buffalo, where he specialized in pediatric pharmacology and translational medicine. His academic achievements include several peer-reviewed publications and industry presentations, highlighting his contributions to the field of pharmacometrics.
Areas of Expertise
- Pharmacokinetic and pharmacodynamic modeling
- Population PK/PD analysis
- Modeling and simulation to support dose selection and study design
- Translational medicine and biomarker development
- Leadership and mentorship of cross-functional teams
Professional Impact
Under Chris's leadership, the Institute for Clinical Pharmacodynamics has played a pivotal role in advancing several novel therapeutic candidates through the drug development pipeline. His expertise in pharmacometrics has enabled the optimization of study designs, informed dose selection, and improved the probability of success in late-stage clinical trials. Chris's contributions have been recognized through multiple industry awards and his active involvement in professional societies, where he shares his knowledge and insights with the broader pharmaceutical community.
Conclusion
With his extensive experience, deep technical expertise, and demonstrated track record of success, Chris Rubino is a respected leader in the field of pharmacometrics. In his current role as Vice President at the Institute for Clinical Pharmacodynamics, he continues to drive innovation and impact in the pharmaceutical industry, with a focus on advancing the development of life-changing therapies.
